VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $224,243 | -61.5% | 23,932 | +0.7% | 0.00% | 0.0% |
| Q2 2023 | $583,127 | +7.1% | 23,772 | +1.6% | 0.00% | 0.0% |
| Q1 2023 | $544,332 | -8.1% | 23,392 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $592,052 | +31.3% | 23,392 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $451,000 | -24.3% | 23,392 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $596,000 | -0.8% | 23,392 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $601,000 | -38.6% | 23,382 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $979,000 | -31.7% | 23,382 | -29.0% | 0.00% | -33.3% |
| Q3 2021 | $1,434,000 | +29.3% | 32,944 | +40.4% | 0.00% | +50.0% |
| Q2 2021 | $1,109,000 | +2.7% | 23,457 | +11.3% | 0.00% | 0.0% |
| Q1 2021 | $1,080,000 | +81.5% | 21,071 | -5.1% | 0.00% | +100.0% |
| Q4 2020 | $595,000 | -22.5% | 22,201 | -0.7% | 0.00% | -50.0% |
| Q3 2020 | $768,000 | -0.5% | 22,361 | +18.6% | 0.00% | 0.0% |
| Q2 2020 | $772,000 | – | 18,851 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |